Clinical Trial Update: Viral Mucosal Reprogramming [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating viral mucosal reprogramming for asthma and allergic rhinitis is currently recruiting. The study is sponsored by The University…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Asthma, Allergic Rhinitis | Phase 2 | Status: RECRUITING